Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. 22-07039.įor Endo: Abigail Davis, Paul Leake and Jason Liberi of Skadden Arps Slate Meagher & FlomĮndo files for bankruptcy as U.S.Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Bankruptcy Court for the Southern District of New York, No. ![]() NOTE: This story has been updated to add a comment from the Oregon Department of Justice. Endo spent $136 million on opioid litigation in 2021, and $32.7 million in the first quarter of 2022, according to its complaint. ![]() "Our position is that the automatic stay does not apply to state police power actions to protect consumers," Edmunson said.īefore filing for bankruptcy, Endo often found itself litigating dozens of opioid lawsuits at a time, and the effort has "impacted nearly every aspect" of its business, the company said. Kristina Edmunson, a spokesperson for the Oregon Department of Justice, confirmed that Oregon is proceeding with litigation against Endo despite the company's bankruptcy. Other state and local governments, including Florida and West Virginia, had previously settled their opioid claims against Endo.Ī Chapter 11 filing usually automatically protects bankrupt companies from litigation by pausing new and ongoing lawsuits, but some state and local governments have argued that the bankruptcy court's "automatic stay" does not apply to government enforcement actions, Endo said in its complaint.Īt least 36 states, as well as attorneys representing local governments in nationwide opioid multi-district litigation proceedings, have agreed to voluntarily pause their lawsuits during Endo's bankruptcy, without conceding that the "automatic stay" applies to them, Endo said.īut others, like Oregon, have told the company that they intend to proceed with litigation against Endo, and many local governments have not made their position clear, according to the complaint. 17, seeking to address its high debt load and resolve more than 3,100 lawsuits accusing the company of deceptively marketing prescription opioids like Opana by downplaying the risk of addiction.īefore filing for bankruptcy, Endo reached a $450 million settlement with more than 30 states to resolve the lawsuits, but it still faces litigation risk from state and local governments that have not agreed to participate in the settlement. bankruptcy court in Manhattan, Endo said if those lawsuits are allowed to continue, the company will not be able to focus on successfully completing its restructuring, including a comprehensive resolution of the opioid claims.Įndo filed for Chapter 11 protection on Aug. opioid epidemic must be paused during the pharmaceutical company's bankruptcy. ![]() Endo International plc sued hundreds of state and local governments on Friday, seeking a ruling that their lawsuits accusing the company of helping fuel the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |